Background: Hydrogen sulfide (H 2 S) is recognized as a gaseous transmitter in mammalian tissues. Several physiological roles for H 2 S including vasodilation, and smooth muscle relaxation have been documented. The exact mechanism explaining its role in uterine contractility remain to be elucidated. The proposed study was conducted to elucidate H 2 S role in uterine contractility in relation to adrenergic and cholinergic systems. Methods: Isolated uterus horn of adult virgin female sprage Dawely rats were used in vitro in physiological saline solution, the effects of H 2 S donor (NaHS), H 2 S blocker aminooxy acetic acid (AOAA) with or without adrenergic and cholinergic drugs and glibenclamide were determined. Results: It was revealed that, NaHS inhibited myometrial contractions as regard the tone and amplitude, whereas AOAA increased the tone of uterine contractility. The relaxant effect of H 2 S on uterine contractility was mediated by modulation of the endogenous adrenergic and cholinergic systems in the myometrium, which was demonstrated by dual interaction of NaHS or AOAA with Adrenaline, Propranolol, Prazosin, Acetylcholine and Atropine on the tone, peak, amplitude and frequency of uterine contractions. Glibencalmide (K ATP channels blocker)
INTRODUCTION
Hydrogen sulfide (H 2 S) is a colorless and rotten egg shell gas, now it is recognized as the third gaseous transmitter in mammalian tissues after carbon monoxide and nitric oxide (NO) (1) .
Two key enzymes, cystathionine-γ-lyase (CSE), cystathionine-β-synthase (CBS), are involved in the natural production of H 2 S in the body utilizing L-cysteine and/or homocysteine as substrate (2 & 3) . Endogenously H 2 S is produced from the amino to increase chloride secretion (7 & 8) . Also, it was found that H 2 S has a role in urogenital tract (9).
It has been reported that H 2 S has a role in gastrointestinal tract secretions and motility.
Additionally, exogenous H 2 S has been shown to protect the gastric mucosa on different model of experimentally induced gastric ulcer in rats (10 & 11 (14) . Little research about the effect of H 2 S on uterine contractions were published, and the exact mechanism explaining the role of H 2 S in uterine motility remain to be elucidated. The proposed study was conducted to elucidate the role of H 2 S in uterine contractility in relation to adrenergic and cholinergic receptors.
Material and methods

Drugs and chemicals
NaHS was used as H 2 S donor, Amino-oxyacetic acid (AOAA) as H 2 S blocker.
Acetylcholine, atropine, adrenaline, propranolol, Glibenclamide were used. All were purchased from Sigma Aldrich Chemical Co (Egypt).
Animals.
24 adult virgin female Sprague Dawely rats (180 -200 g) in oestrus state, were used in the study, and determined by daily vaginal smear examination. All experiments were performed in accordance with the guidelines and principles for the care and use of laboratory animals at Mansoura University.
Tissue Preparation and Organ Bath.
Animals were killed by cervical dislocation. All experiments were carried out at 37 C, and the PSS was continuously gassed with 95% O2 -5% CO2. A resting tension of 0.5 g was applied, and the uteri were allowed to contract spontaneously during an initial equilibration period of 30-60 min before commencing any experimental protocol. Following the equilibration period and development of spontaneous contractile activity, control contractions were recorded for 10 min. and various concentrations of drug were added to the tissue bath cumulatively (16).
The amplitude (in gm) and frequencies (number of contractions in 10 min) of contractions were evaluated at 10-min intervals before and after applications of each dose of the drug.
Experimental design
The record of basal uterine contractility (before application of the drug) acts as the control compared with the record of uterine contractility after application of the drug on the uterine tissue in the organ path.
To study the role of H 2 S on uterine contractility and its relation to adrenergic and cholinergic neuron interaction through the following experiments (6 rats each):
1) Group 1 experiments: The effect of H 2 S on uterine contractility by using NaHS (as H 2 S donors) in a dose of (1 mM/L), and or Aminooxy-acetic acid AOAA (H 2 S synthesis blocker) in a dose of (1 mM/L) (17).
2) Group 2 experiments: Effect of H 2 S on adrenergic stimulated uterine contractility by using AOAA (in a dose of (1 mM/L)) or NaHS (in a dose of (1 mM/L)) on adrenergic agonist (adrenaline, in a dose of (1 µM/L)) and antagonists alpha blocker (prazosin, in a dose of (1 µM/L)) and beta blockers (propranolol, in a dose of (1 µM/L)) (18).
3) Group 3 experiments:
Effect of H 2 S on cholinergic stimulated uterine contractility by using AOAA (in a dose of (1 mM/L)) or NaHS (in a dose of (1 mM/L)) on cholinergic agonist (acetylcholine, in a dose of (0.1 mM/L)) and antagonists (atropine, in a dose of (1 µM/L)) (18).
4) Group 4 experiments:
Effect of Glibenclamide (K ATP channels blocker, in a dose of (6 µM/L)) on H 2 S modulated uterine contractility, by using AOAA (in a dose of (1 mM/L)) or NaHS (in a dose of (1 mM/L))
. 
Data analysis and statistical procedures
Results
The responses were quantified by calculating the tone of uterine segment was determined by the base of contraction, the amplitude of contractions was determined by the extent from the base to the peak of contraction and frequency of the contractions. The rate was determined by counting the number of contractions over a 10-minute period before the next addition of the drug.
1) Effect of H 2 S donor (NaHS) or H 2 S blocker (AOAA) on the uterine motility:
The effect of increased H 2 S on uterine contractility It was found that NaHS significantly decreased the base (tone), peak and amplitude of uterine contractions (P= 0.005, 0.028, 0.023) as compared with the basal uterine contractions, but NaHS significantly increased the frequency of uterine contractility from 8.8 ± 0.84 to 14.4 ± 0.547 (P < 0.001) ( Fig. 1 A & Table1).
Effect of endogenous H 2 S on uterine contractility
It was found that AOAA that block H 2 S synthesis produced significant increase in the tone (P= 0.005), but insignificant decrease in amplitude of uterine contractions. Whereas AOOA significantly increased the rate of contractions (P < 0.001) as compared with basal uterine contractions.
Meanwhile NaHS after AOAA produced significant decrease in the tone (P= 0.005) as compared with that of AOAA and significant decrease in the rate of contraction (P= 0.009) as compared with that of AOAA, that was still significantly higher than the basal contractions (P < 0.001) ( Fig. 1 B & Table 2 ).
2) Effect of H 2 S donor (NaHS) or H 2 S blocker
(AOAA) on the adrenergic modulated uterine motility:
Adrenaline and H 2 S on uterine contractions.
It was also found that adrenaline significantly decreased the base (tone), the peak and the amplitude of uterine contractions (P= 0.003), also significantly decreased the frequency of contractions from 11.2 ± 0.84 to 3.6 ± 0.547 (P < 0.001) as compared with the basal contractions.
Whereas AOAA after adrenaline significantly increased the peak and amplitude (P= 0.003), also significantly increased the frequency of contractions from 3.6 ± 0.547 to 8.4 ± 1.67 (P < 0.001), that was still significantly lower than the basal contractions ( Table 2 ).
Beta blocker and H 2 S on uterine contractions
The study revealed that NaHS significantly decreased the peak and amplitude (P= 0.006, 0.005) respectively, but significantly increased the frequency of contractions from 7 ± 0.63 to 9.3 ± 0.84 (P= 0.02), meanwhile the base (tone)
insignificantly decreased as compared with the basal uterine contractions. Whereas propranolol after NaHS significantly increased the base (tone), peak and amplitude (P= 0.01, 0.003, 0.003) respectively as compared with that of NaHS, also the base (tone) became significantly higher than the basal uterine contractions (P= 0.005) (Fig 2 B , Table 1 ).
It was also found that propranolol significantly increased the base (tone) (P= 0.016), but 
Alpha blocker and H 2 S on uterine contractions
It was found that NaHS significantly decreased the base (tone), the peak and the amplitude (P= 0.016. 0.008, 0.008) respectively, but significantly increased the frequency of uterine contractions from 12.5 ± 0.577 to 15.5 ± 0.577 (P = 0.005) as compared with the basal one. Whereas prazosin after NaHS produced insignificant changes in the uterine contractility as regard the base (tone), peak, amplitude and the frequency as compared with that of NaHS, but the peak and the amplitude were still significantly lower than that of basal contractions (P= 0.037, 0.028) respectively meanwhile the frequency of contractions was still significantly higher than that of basal contractions (Fig 2 D 
.
Prazosin significantly decreased the base (tone), peak, amplitude and frequency of uterine contractions (P= 0.008, 0.001, 0.023, 0.015) as compared with the basal one. Whereas NaHS after prazosin significantly decreased the tone, peak and amplitude of contractions (P= 0.002, 0.003, 0.009)
as compared with that of prazosin but these parameters were still significantly lower than that of basal contractions (Fig 2 E, Fig 6) .
AOAA significantly increased the tone but AOAA (H 2 S synthesis blocker) on basal uterine contractions followed by NaHS, C) NaHS on basal uterine contractions followed by AOAA.
Fig 2:
Effect of H 2 S on adrenergic modulated uterine contractions. A) adrenaline on basal uterine contractions followed by AOAA (H 2 S synthesis blocker), B) NaHS ( H 2 S donor) on basal uterine contractions followed by propranolol (non selective B blocker), C) propranolol on basal uterine contractions followed by NaHS, D) NaHS on basal uterine contractions followed by prazosin (alpha blocker), E) AOAA on basal uterine contractions followed by prazosin (alpha blocker), F) prazosin on basal uterine contractions followed by AOAA (H 2 S synthesis blocker).
3) Effect of H 2 S donor (NaHS) or H 2 S blocker (AOAA) on the cholinergic modulated uterine motility:
It was found that acetylcholine significantly increased the base (tone), peak and amplitude (P= 0.006, 0.005, 0.002) respectively, but significantly increase the frequency of contractions from 7 ± 0.63 to 14 ± 0.84 (P= 0.002), as compares with the basal uterine contractions. Whereas NaHS after acetylcholine significantly decreased the base (tone), peak and amplitude of uterine contractions (P= 0.001, 0.003, 0.003) respectively as compared with that of Ach ( Fig 3A ) .
NaHS significantly decreased the base (tone), peak and amplitude of uterine contractions (P= 0.005, 0.008, 0.023) as compared with the basal contractions, also it significantly decreased the frequency from 11.6 ±0.55 to 9.2 ±0.84 (P=0.009).
Whereas atropine after NaHS insignificantly decreased the tone, peak and amplitude but significantly decreased the frequency of uterine contractions from 9.2 ±0.84 to 6.2 ±0.84 (P=0.001)
as compared with that of NaHS, these reduction in the uterine contractility parameter became more significantly lower than the basal contractions (P= 0.005, 0.002, 0.002, <0.001) (Fig 3 B & Fig 6) .
AOAA significantly increased the base (tone) (P= 0.017) and frequency of contractions from 10.8
±0.84 to 13 ±0.71 (P= 0.011), but significantly decrease the peak (P= 0.041), as compared with the basal contractions. Whereas atropine after AOAA significantly decrease the base (tone), peak of uterine contractions (P= 0.003, 0.004) as compared with that of AOAA, also became significantly lower than the basal contractions (P= 0.003). Atropine significantly decreased the frequency of uterine contractions from 13 ±0.71 to 10 ±0.71 (P= 0.011) as compared with that of AOAA (Fig 3 C & Table 2 ).
Fig 3:
Effect of H 2 S on cholinergic modulated uterine contractions. A) acetylcholine on basal uterine contractions followed by NaHS (H 2 S donor), B) NaHS on basal uterine contractions followed by atropine (muscarinic blocker), C) AOAA (H 2 S synthesis blocker) on basal uterine contractions followed by atropine (muscarinic blocker).
Fig 4:
Role of Glibenclamide (K ATP channel blocker) in H 2 S modulated uterine contractions. A) NaHS (H 2 S donor) on basal uterine contractions followed by Glibenclamide, B) AOAA (H 2 S synthesis blocker) on basal uterine contractions followed by Glibenclamide. Table 2 ).
Discussion
The numerous physiological mechanisms that control myometrial contractility involving the (27), and that H 2 S bind to metalcontaining proteins, thus potentially interfering with the contraction mechanism of smooth muscle by uncoupling the electron transport chain (28). It is possible that low levels of H 2 S could inhibit ATP production and therefore reduce contractility in smooth muscle cells (29). It has been shown that physiological concentrations of H 2 S increase the production of cyclic AMP in neurons and oocytes in culture (30). Increased intracellular levels of cAMP are known to relax smooth muscles.
It has been shown in previous animal studies that, in parallel with the β2-adrenoceptors (β2-AR), the α1-adrenoceptors (α 1-AR) also play a major role in the regulation of myometrium contractility (31). The density of α1-AR in the rat myometrium was found to be increased by the end of gestation, which suggests that these receptors are involved in the increase of uterine contractility The muscarinic receptors blocker, atropine after NaHS produces insignificant changes in the tone, the peak and amplitude, but significantly decreases the frequency of uterine contractions as compared with that of NaHS, these reductions in the uterine contractility parameters become more significantly lower than the basal contractions.
The modulatory effect of H 2 S on endogenous cholinergic system supported by the finding that the muscarinic receptors antagonist, atropine after AOAA that block the endogenous H 2 S, significantly decreases the base (tone), peak and frequency of uterine contractions as compared with that of AOAA. These means that the blocked release of H 2 S allow endogenous ACh to act that action blocked by muscarinic antagonist atropine. Of note, K ATP channels were identified to mediate the vasodilatory effects of H 2 S (45).
Previous studies have shown that H 2 S suppresses the spontaneous contraction of human myometrial strips via K ATP channels (25). Our results showed that glibenclamide (K ATP channels blocker) after NaHS significantly increase the base (tone), the peak and amplitude of uterine contractions, but insignificantly lowers the frequency of contractions as compared with that of NaHS.
However, glibenclamide after AOAA produces no significant changes in the base (tone), peak and amplitude of uterine contractions, but significantly increases the frequency of contractions as compared with that of AOAA. These findings indicate that the relaxant effect of H 2 S on the contractility of rat myometrium is mediated by K ATP channels. Our results are in consistent with many previous studies on smooth muscles and K ATP channels. It was demonstrated that H 2 S activates K ATP channel, thereby causing relaxation of smooth muscle (46). For instance, it was suggested that vasorelaxation induced by H 2 S in rat aorta and mesenteric beds is mainly caused by K ATP channel opening (23 and 47). The study by
Zhao et al has also has shown that K ATP channels mediated NaHS-induced relaxation of spontaneous contractions of gastric smooth muscle (48).
Also, it was demonstrated that blockage of K ATP channels reversed H 2 S suppression of proinflammatory cytokines. A number of studies have implicated that H 2 S actually exerts its function by modifying l-cysteine in a large number of proteins by S-sulfhydration (49 and 50).
Moreover, it has been reported that H 2 S regulates K ATP channels via sulfhydration of l-cysteine in these proteins (49 and 51).
In conclusion, the myometrium smooth muscle cells express CBS and CSE. Endogenous H 2 S generated through CSE and CBS locally modulates the contractility of myometrium. The inhibitory effect of H 2 S on uterine contractility is through modulation of the endogenous adrenergic and cholinergic systems and activation of K ATP channels.
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